Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > What's Being Traded: Old or New B Warrants?

<< Previous

Bullboard Posts

Next >>

Comment by Chritterson Jul 23, 2021 2:24pm

147 Views

Post# 33596914

RE:RE:RE:What's Being Traded: Old or New B Warrants?

It takes 2-5 Days for most trading platforms to make the proper changes, This should have been halted til the terms were released. What your seeing now will be changed then, This is why they are not allowing you to sell shares until its all corrected

Whyme16 wrote: I'm with TD and my B warrants quantity are 1/20 of that from yesterday (i.e. 1:20 RS) BUT the price shown as 0.02 rather than closer to 10 cents!

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing